Loading...

Home
ETF
TEM

TEM

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

TEM News

Ventripoint Joins Global Congenital Heart Disease Alliance to Enhance Care Access

4d agoNewsfilter

Tempus AI Receives FDA Clearance for Atrial Fibrillation Prediction Software

Jun 11 2026Newsfilter

ExomeReveal RNA Analysis Enhances Genetic Diagnosis Clarity

Jun 09 2026Newsfilter

Tempus AI Expands Beyond Diagnostics with Healthcare Data Platform

Jun 08 2026Fool

Tempus AI Aims for Profitable Growth Potential Beyond Diagnostics

Jun 08 2026NASDAQ.COM

AstraZeneca CEO Discusses AI's Role in Drug Development

Jun 05 2026CNBC

Tempus AI Launches Digital Pathology Open-Source Consortium

Jun 03 2026Newsfilter

Tempus AI Launches Next-Generation Genetic Test for Oncology

Jun 01 2026Newsfilter

Tempus Launches Next-Gen AI Platform Lens to Accelerate Drug Development

May 31 2026Newsfilter

Tempus Launches PRECISION Challenge to Accelerate Oncology Breakthroughs

May 30 2026Newsfilter

Tempus AI Launches Rapid Clinical Insights Application

May 30 2026Newsfilter

Tempus AI Unveils New AI-Driven Precision Medicine Data

May 29 2026seekingalpha

Tempus AI Unveils Latest Results on Multimodal Foundation Models

May 29 2026Newsfilter

Tempus AI Receives FDA Approval for Tumor-Only Testing

May 29 2026NASDAQ.COM

Tempus AI Receives FDA Approval for Tumor-Only Testing

May 29 2026Newsfilter

Cathie Wood's Investment Strategy Analysis

May 28 2026Fool